Ignite Creation Date:
2025-12-25 @ 3:20 AM
Ignite Modification Date:
2026-03-09 @ 4:38 PM
Study NCT ID:
NCT03915405
Status:
TERMINATED
Last Update Posted:
2024-04-25
First Post:
2019-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer
Sponsor:
Kyowa Kirin, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-26
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-15
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-19
First Submit QC Date:
None
Study First Post Date:
2019-04-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-24
Last Update Post Date:
2024-04-25
Last Update Post Date Type:
ACTUAL